The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApax Global Alpha Regulatory News (APAX)

Share Price Information for Apax Global Alpha (APAX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 141.00
Bid: 140.40
Ask: 141.00
Change: 0.00 (0.00%)
Spread: 0.60 (0.427%)
Open: 141.40
High: 142.00
Low: 140.40
Prev. Close: 141.00
APAX Live PriceLast checked at -
Apax Global Alpha is an Investment Trust

To provide shareholders with capital appreciation from our investment portfolio and regular dividends.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2016 Interim Financial Highlights

17 Aug 2016 07:00

RNS Number : 3613H
Apax Global Alpha Limited
17 August 2016
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, INTO OR WITHIN THE UNITED STATES OR TO "US PERSONS" (AS DEFINED IN REGULATION S UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT")) OR INTO OR WITHIN AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN. RECIPIENTS OF THIS ANNOUNCEMENT IN JURISDICTIONS OUTSIDE THE UK SHOULD INFORM THEMSELVES ABOUT AND OBSERVE ANY APPLICABLE LEGAL REQUIREMENTS IN THEIR JURISDICTIONS. IN PARTICULAR, THE DISTRIBUTION OF THE ANNOUNCEMENT MAY BE RESTRICTED BY LAW IN CERTAIN JURISDICTIONS.

Note that references in this announcement to Apax Global Alpha Limited have been abbreviated to "AGA" or "the Company". References to Apax Partners LLP have been abbreviated to "Apax Partners" or "the Investment Adviser"

FOR IMMEDIATE RELEASE

17 August 2016

(LSE: APAX)

Apax Global Alpha Limited

Unaudited Interim Results for the period ended 30 June 2016

 

For further information regarding the announcement of AGA's 2016 Interim Report and Accounts, including the details for today's analyst and investor webcast at 9.30am (UK time), please visit www.apaxglobalalpha.com/investor-information/calendar

 

Financial highlights for the six months to 30 June 2016

· Adjusted NAV of €894.4m, down from €923.6m at 31 December 2015

· Adjusted NAV per share of €1.82 (£1.52), compared to €1.88 (£1.38) at 31 December 2015

· Second semi-annual dividend declared of 3.95 pence per share, equivalent to 2.5% of euro NAV at 30 June 2016 of €22.5m will be paid on 14 September 2016

· First semi-annual dividend paid of 3.69 pence per share, equivalent to 2.5% euro NAV at 31 December 2015 of €23.4m was paid in April 2016

· Total Return was negative 0.6%. On a constant currency basis, Total Return was positive 0.6%

· AGA was 94% invested and had a cash balance of €48.5m

 

Investment highlights for the six months to 30 June 2016

· Well-balanced invested portfolio: Private Equity (52%) and Derived Investments (48%)

· Sector exposure balanced across all Apax Partners' focus industries. Tech & Telco was the most heavily weighted sector, accounting for 37% of the invested portfolio

· Geographic bias towards North America, representing 59% of the invested portfolio

 

Performance

· Portfolio was stable in a difficult market environment. Portfolio performance was broadly neutral with a Total Return of -0.6% up to 30 June 2016.

· Private Equity had a positive performance of 0.9% largely driven by strong operational performance from the underlying portfolio companies, somewhat offset by lower valuation multiples.

· Derived Investments were down 0.4%. Positive interest income was offset by write-downs for a small number of Debt Investments.

 

Private Equity - Operational Metrics

30 June 2016

31 December 2015

Portfolio year-over-year Last Twelve Months (LTM) revenue growth(1)

7.4%

7.8%

Portfolio year-over-year LTM EBITDA growth(1)

9.8%

9.0%

Average EV/EBITDA multiple(1)

11.9x

12.4x

Average net debt / EBITDA(1)

4.4x

4.6x

Number of new investments(2)

1

9

Number of exits(2)

7

4

 

· Private Equity portfolio highlights:

o Apax Funds have returned €38.7m to AGA in H1 2016, despite a weakened exit environment

o Apax VIII closed one new investment, which was bridge-funded by the fund's capital call facility. In addition Apax VIII announced three new investments signed up during H1 2016

o Aggregate IRR generated on exited investments was 36% for the Private Equity portfolio

 

Derived Investments - Operational Metrics

30 June 2016

31 December 2015

Yield to maturity(3) of debt investments

12.7%

11.5%

Average years to maturity for debt investments (in years)

5.6

6.1

Average income yield(4) of debt investments

10.1%

9.6%

Year-over-year LTM EBITDA growth debt investments(5)

1.3%

5.0%

Year-over-year LTM earnings growth equity investments(6)

18.5%

14.8%

Average P/E multiple(7) of equity investments

17.9x

20.0x

Number of new investments(8)

5

10

Number of full exits(9)

6

3

 

· Derived Investments portfolio highlights:

o Fully exited two debt investments and four listed equity investments, realising total proceeds of €51.9m. The aggregate IRR on these realisations was 26.7%. In addition, proceeds from partial realisations totalled €20.7m

o In the 6 months to 30 June 2016, AGA made one new investment in debt, four new investments in listed equities and one add-on investment in equities, totalling €65.2m

 

Commenting on the results, Tim Breedon CBE, Chairman of Apax Global Alpha, said:

"I am pleased to present the Company's 2016 half year results, which I believe demonstrate the resilience of the AGA portfolio. Despite challenging market conditions, the portfolio finished only marginally down for the first half of the year with a negative 0.6% Total Return. This was primarily due to income from Derived Investments and positive Private Equity performance being offset by Derived Investments unrealised losses and adverse FX."

"I believe that AGA continues to represent an attractive long-term investment for our shareholders and we continue to build and maintain a portfolio with considerable returns potential."

Commenting on AGA's investment focus, Nico Hansen, CIO of Apax Partners, said:

"The volatile conditions presented some challenges in the first quarter and tested the portfolio's fundamentals. AGA has held up well in the first half, with improving performance in the second quarter."

"I'm satisfied with the Private Equity portfolio's performance. Derived Investments were more mixed: interest income was strong but was offset by a small number of debt valuation declines. We believe overall performance will reverse across the positions which currently see mark to market valuation declines."

 

Financial highlights

Private Equity

€m

Derived Investments

€m

Cash

 

€m

Others

 

€m

Total

 

€m

Adjusted NAV as of 31 December 2015

469.4

432.4

22.9

(1.1)

923.6

+ Investments

-

65.2

(65.2)

-

-

- Divestments

(38.7)

(72.6)

107.1

4.2

-

+ Interest and dividend income

-

-

14.5

2.3

16.8

+/- Unrealised FV movement

8.4

(16.7)

-

-

(8.3)

+/- Realised FV movement

-

(1.9)

-

-

(1.9)

+/- FX losses

(3.0)

(7.3)

(0.7)

-

(11.0)

+/- Costs and others

-

-

(4.7)

(0.9)

(5.6)

- Dividends paid

-

-

(23.4)

-

(23.4)

+/- performance fee reserve

(1.1)

7.3

(2.0)

-

4.2

Adjusted NAV as of 30 June 2016

435.0

406.4

48.5

4.5

894.4

 

 

Invested portfolio analysis at 30 June 2016

 

Asset class

 

 

€m

 

€m

 

%

 

%

Private Equity

440.3

52

- AEVI

2.9

0

- AE VII

79.8

9

- AE VIII

353.1

42

- AMI

4.5

1

Derived Investments

407.8

48

- Debt

314.5

37

- Equities

93.3

11

Total

848.1

848.1

100

100

 

Sector mix

 

€m

Invested portfolio

%

Private Equity

%

Derived Investments

%

Tech & Telco

313.2

37

36

38

Services

234.3

28

31

24

Consumer

157.8

19

18

20

Healthcare

131.0

15

14

17

Other

11.8

1

1

1

Total

848.1

100

100

100

 

Geographic analysis

 

€m

Invested portfolio

%

Private Equity

%

Derived Investments

%

North America

500.4

59

51

68

UK

23.2

2

3

3

Switzerland

15.6

2

0

4

Rest of Europe

190.9

23

34

10

India

85.3

10

7

13

China

13.5

2

1

2

RoW

19.2

2

4

0

Total

848.1

100

100

100

 

Summary of top 10 investments in Private Equity and Derived Investments

Valuation

€m

NAV

%

Invested portfolio

%

 Top 10 Private Equity

 EVRY ASA

42.5

5

5

 GlobalLogic Inc.

41.7

5

5

 Assured Partners

35.5

4

4

 Exact Software

31.4

3

4

 Azelis S.A.

26.6

3

3

 One Call / Align

26.1

3

3

 Full Beauty

24.3

3

3

 Wehkamp

23.7

3

3

 Idealista

17.6

2

2

 Shriram City

17.4

2

2

 Other

153.5

16

18

Total Private Equity

440.3

49

52

Top 10 Derived Investments

 Full Beauty

30.8

3

4

 Ellucian

27.3

3

3

 Epicor

21.0

2

2

 Azelis S.A.

19.7

2

2

 Genex

19.2

2

2

 Compuware

18.8

2

2

 Acelity (Kinetic Concepts)

18.4

2

2

 Assured Partners

17.7

2

2

 Advantage Sales & Marketing

17.1

2

2

 Strides Shasun

17.0

2

2

 Other

200.8

23

25

Total Derived Investments

407.8

45

48

Total Investments

848.1

94

100

Cash

48.5

5

0

Net current assets

4.5

1

0

Total NAV

901.1

100

0

Performance fee reserve

(6.7)

Total Adjusted NAV

894.4

 

Contact details

Investor Relations

Sarah Wojcik

Telephone:

+44 (0)20 7872 6300

Email:

investor.relations@apaxglobalalpha.com

Media enquiries (Apax Global Alpha Limited)

Georgiana Brunner/Annabel Clay, Greenbrook Communications

Telephone:

+44 (0)20 7952 2000

Email:

aga@greenbrookpr.com

Media enquiries (Apax Partners LLP)

Alex Wessendorff

Telephone:

+44 (0)20 7872 6461

Email:

alex.wessendorff@apax.com

Company Secretary

Matt Horton/Jacques Colley, Aztec Group

Telephone:

+44 (0)1481 749 700

Email:

AGA-Admin@aztecgroup.co.uk

 

Notes

 

1. The information presented herein is not an offer for sale within the United States of any equity shares or other securities of Apax Global Alpha Limited ("AGA"). AGA has not been and will not be registered under the US Investment Company Act of 1940, as amended (the "Investment Company Act"). In addition, AGA's shares (the "Shares") have not been and will not be registered under the Securities Act or any other applicable law of the United States. Consequently, the Shares may not be offered or sold or otherwise transferred within the United States, or to, or for the account or benefit of, US Persons, except pursuant to an exemption from the registration requirements of the Securities Act and under circumstances which will not require AGA to register under the Investment Company Act. No public offering of the Shares is being made in the United States.

2. This announcement may include forward-looking statements. The words "expect", "anticipate", "intends", "plan", "estimate", "aim", "forecast", "project" and similar expressions (or their negative) identify certain of these forward-looking statements. These forward-looking statements are statements regarding AGA's intentions, beliefs or current expectations concerning, among other things, AGA's results of operations, financial condition, liquidity, prospects, growth and strategies. The forward-looking statements in this presentation are based on numerous assumptions regarding AGA's present and future business strategies and the environment in which AGA will operate in the future. Forward-looking statements involve inherent known and unknown risks, uncertainties and contingencies because they relate to events and depend on circumstances that may or may not occur in the future and may cause the actual results, performance or achievements of AGA to be materially different from those expressed or implied by such forward looking statements. Many of these risks and uncertainties relate to factors that are beyond AGA's ability to control or estimate precisely, such as future market conditions, currency fluctuations, the behaviour of other market participants, the actions of regulators and other factors such as AGA's ability to continue to obtain financing to meet its liquidity needs, changes in the political, social and regulatory framework in which AGA operates or in economic or technological trends or conditions. Past performance should not be taken as an indication or guarantee of future results, and no representation or warranty, express or implied, is made regarding future performance. AGA expressly disclaims any obligation or undertaking to release any updates or revisions to these forward-looking statements to reflect any change in AGA's expectations with regard thereto or any change in events, conditions or circumstances on which any statement is based after the date of this announcement, or to update or to keep current any other information contained in this announcement. Accordingly, undue reliance should not be placed on the forward-looking statements, which speak only as of the date of this announcement.

Footnotes 

(1) Represents the weighted average of the respective metrics across the underlying portfolio companies, using latest available information

 

(2) Represents investments and exits during the half year ended at the indicated date. New investments during H2 2015 includes Azelis' acquisition of Koda which required additional equity investment from the Apax Private Equity Funds. During H1 2016 there were 4 full closed exits (Rhiag, King, Auto Trader and Tommy Hilfiger China) and 3 closed partial exits represented by the IPO of Ascential, a secondary sale of Capio shares in Q1 2016 and partial sale of shares in Garda. The above number of exits excludes the recapitalisation of Evry

 

(3) GAV weighted average yield to maturity (YTM) of the Derived Debt Investments

 

(4) GAV weighted average of the current full year income (annual coupon/clean price as at 30 June 2016) for each debt position in the Derived Debt Investments at 30 June 2016

 

(5) GAV weighted average of latest available EBITDA growth, since prior year, of the underlying Derived Debt Investments

 

(6) GAV weighted average of the latest earnings growth, since prior year, of the underlying Derived Equity Investments. Excludes Palo Alto

 

(7) GAV weighted Price Earnings multiple of Derived Equity Investments

 

(8) New investments in debt in the 6 months to 30 June 2016 were in Ellucian and four completed new equity positions in Sophos, Palo Alto, Fortinet, and Edelweiss. December comparison is for the six months ending at the indicated date

(9) Disposals in 6 months to 30 June 2016 consisted of debt realisations in Physiotherapy and Exact first lien debt and equity realisations in Greene King, Zhaopin, Karur Vysya Bank Ltd and Sinopharm. December comparison is for the six months ending at the indicated date.

 

 

About Apax Global Alpha Ltd

AGA is a Guernsey registered closed-ended collective investment scheme incorporated as a non-cellular company that listed on the London Stock Exchange on 15 June 2015. It is regulated by the Guernsey Financial Services Commission.

AGA's objective is to provide shareholders with capital appreciation from its investment portfolio and regular dividends. The Company is targeting an annualised Total Return, across economic cycles, of 12-15% (net of fees and expenses) including a dividend yield of 5% of Net Asset Value (NAV), once fully invested.

 

The investment policy of the Company is to make private equity investments in Apax Funds and Derived Investments which are investments in equities and debt derived from the insights gained via Apax Partners' Private Equity activities. The Company's portfolio is expected to be allocated in approximately equal proportions between Private Equity and Derived Investments, although the investment mix will fluctuate over time due to market conditions, investment opportunities, cash flow requirements, the dividend policy and other factors.

Further information regarding the Company and its publications are available on the Company's website at www.apaxglobalalpha.com

 

About Apax Partners LLP

 

Apax Partners LLP ("Apax Partners") is a leading global private equity advisory firm. It operates globally and has more than 30 years of investing experience. Apax Partners has advised funds that total over €40 billion in aggregate as at 30 June 2016. Funds advised by Apax Partners invest in companies across four global sectors of Tech & Telco, Services, Healthcare and Consumer. These funds provide longterm equity financing to build and strengthen worldclass companies. For further information about Apax Partners, please visit www.apax.com.

 

Apax Partners LLP is authorised and regulated by the Financial Conduct Authority in the UK.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR SFWFMMFMSELA
Date   Source Headline
24th Apr 20247:00 amRNSApax Funds to acquire IANS
18th Apr 20247:00 amRNSApax Funds To Acquire Zellis Group
5th Apr 20249:58 amRNSDirector/PDMR Shareholding
4th Apr 20242:02 pmRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSNotice of Capital Markets Day
22nd Mar 202410:08 amRNSHolding in Company
11th Mar 20245:17 pmRNSPurchase of Ordinary Shares under IMA
5th Mar 20247:00 amRNS2023 Annual Dividend Declaration
5th Mar 20247:00 amRNSNotice of AGM
5th Mar 20247:00 amRNS2023 Annual Report and Accounts
5th Mar 20247:00 amRNS2023 Final Results
1st Mar 20242:00 pmRNSRetirement of Chris Ambler from the Board
28th Feb 20247:00 amRNSApax Funds Acquire IES
8th Feb 20247:00 amRNSEstimated Adjusted NAV as at 31 December 2023
2nd Feb 20247:00 amRNSApax Funds Acquire WGSN
4th Dec 20233:00 pmEQSHardman & Co Q&A on Apax Global Alpha: Hidden gems strategy delivering new investment opportunities
23rd Nov 202312:43 pmEQSHardman & Co Research on Apax Global Alpha (APAX): “Hidden Gems” strategy: green shoots into live deals
17th Nov 202312:58 pmRNSDirector/PDMR Shareholding
15th Nov 20237:00 amRNSApax Funds Invest in Petvisor
9th Nov 20237:00 amRNSQuarterly Results to 30 September 2023
27th Oct 20237:00 amRNSApax Funds Acquire GAN Integrity
12th Oct 20232:15 pmEQSHardman & Co Q&A on Apax Global Alpha (APAX): Confirming strong underlying competitive advantages
11th Oct 20237:00 amRNSApax Funds acquire Bazooka Candy Brands
5th Oct 20237:00 amRNSNotice of Q3 2023 Financial Results
2nd Oct 20237:00 amRNSDirectorate Change
25th Sep 20235:06 pmRNSHolding in Company
25th Sep 20232:45 pmEQSHardman & Co Research on Apax Global Alpha (APAX): Resilience in face of rising interest rates
12th Sep 202311:30 amRNSDirector/PDMR Shareholding
6th Sep 20237:02 amRNS2023 Interim Dividend
6th Sep 20237:01 amRNS2023 Interim Report and Accounts
6th Sep 20237:00 amRNS2023 Interim Results Highlights
7th Aug 20237:00 amRNSEstimated Adjusted NAV as at 30 June 2023
1st Aug 20237:00 amRNSFunds advised by Apax to acquire Palex
20th Jul 20234:35 pmEQSHardman & Co Q&A on Apax Global Alpha (APAX) Capital Markets Day: value added by the manager
5th Jul 20233:50 pmEQSHardman & Co Research on Apax Global Alpha (APAX) 2023 Capital Markets Day: accessing hidden gems
2nd Jun 20237:00 amRNSFunds advised by Apax invest in Swing Education
23rd May 20237:00 amRNSNotice of Capital Markets Day
16th May 20237:00 amRNSFunds advised by Apax to acquire IBS Software
4th May 20237:00 amRNSResult of AGM
4th May 20237:00 amRNSQuarterly results for 31 March 2023
21st Mar 20232:05 pmEQSHardman & Co Q&A on Apax Global Alpha (APAX): 2022 results adding value to companies leads to outperformance
14th Mar 20232:05 pmEQSHardman & Co Research on Apax Global Alpha (APAX): Outperformance by adding value to companies
13th Mar 20237:00 amRNSUpdate relating to SVB
2nd Mar 20237:00 amRNS2022 Annual Dividend Declaration
2nd Mar 20237:00 amRNSNotice of AGM
2nd Mar 20237:00 amRNS2022 Annual Report and Accounts
2nd Mar 20237:00 amRNS2022 Final Results
2nd Feb 20237:00 amRNSThe Apax Digital Fund II invests in Magaya
2nd Feb 20237:00 amRNSApax Funds’ Valuations and Credit Facility update
24th Jan 202310:15 amEQSHardman & Co Q&A on Apax Global Alpha (APAX): Adding value to private companies

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.